Cullinan Therapeutics (CGEM) Q4 2023 Earnings

14MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.42
-1.13
-0.83
-0.54

Details

Expected EPS
-0.961429
Actual EPS
-0.54
Surprise EPS
0.42
Surprise Percent
+43.83%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.54 per share for Q4 2023.

0 Comments

Share your thoughts